Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-11.1%
5Y CAGR+15.3%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-11.1%/yr
vs +90.0%/yr prior
5Y CAGR
+15.3%/yr
Recent deceleration
Acceleration
-101.0pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $21.56M | -24.9% |
| 2024 | $28.72M | -0.6% |
| 2023 | $28.88M | -5.8% |
| 2022 | $30.65M | +13.7% |
| 2021 | $26.96M | +154.6% |
| 2020 | $10.59M | +176.4% |
| 2019 | $3.83M | +62.7% |
| 2018 | $2.35M | - |